Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: best news in the history of the company and management is going

Swartz didn't take as huge a risk as some here seem to think. I recall Schwartz placing a lean on the patents when he PIPE'd us so that if PTSC went bankrupt he would get PTSC's portion of the patents which he could then go on to consolidate with TPL leaving the share holders out to dry. Thank god that didn't happen but don’t be fooled into thinking Swartz took an enormous amount of risk with this investment. It was shareholders that were bearing the real risk.

Share
New Message
Please login to post a reply